Monica Gardon, Mohan K Raizada, Michael J Katovich, Kathleen H Berecek, and Craig H Gelband

Gene therapy for hypertension and restenosis
J Renin Angiotensin Aldosterone Syst 2000 1: 211-216. [PDF] [References]  

Marc S Weinberg, Adam J Weinberg, and Dion H Zappe

Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors
J Renin Angiotensin Aldosterone Syst 2000 1: 217-233. [PDF] [References]  

Carl Erik Mogensen

ACE inhibitors and antihypertensive treatment in diabetes: focus on microalbuminuria and macrovascular disease
J Renin Angiotensin Aldosterone Syst 2000 1: 234-239. [PDF] [References]  

Dirk C Felmeden and Gregory YH Lip

The renin-angiotensin-aldosterone system and fibrinolysis
J Renin Angiotensin Aldosterone Syst 2000 1: 240-244. [PDF] [References]  

William Stephen Waring

Early initiation of ACE inhibitor treatment after acute myocardial infarction - a missed therapeutic opportunity?
J Renin Angiotensin Aldosterone Syst 2000 1: 245-251. [PDF] [References]  

Michael S Gordon, Deborah A Price, and Norman K Hollenberg

Blunted suppression of plasma renin activity in diabetes
J Renin Angiotensin Aldosterone Syst 2000 1: 252-256. [Abstract] [PDF] [References]  

Yi Zhun Zhu, Yi-Chun Zhu, Jun Li, Heiner Schäfer, Wolfgang Schmidt, Tai Yao, and Thomas Unger

Effects of losartan on haemodynamic parameters and angiotensin receptor mRNA levels in rat heart after myocardial infarction
J Renin Angiotensin Aldosterone Syst 2000 1: 257-262. [Abstract] [PDF] [References]  

Ewa Chabielska, Tomasz Matys, Iwona Kucharewicz, Dariusz Pawlak, Roland Rólkowski, and Wlodzimierz Buczko

The involvement of AT2-receptor in the antithrombotic effect of losartan in renal hypertensive rats
J Renin Angiotensin Aldosterone Syst 2000 1: 263-267. [Abstract] [PDF] [References]  

Iwona Kucharewicz, Ewa Chabielska, Dariusz Pawlak, Tomasz Matys, Roland Rólkowski, and Wlodzimierz Buczko

The antithrombotic effect of angiotensin-(1—7) closely resembles that of losartan
J Renin Angiotensin Aldosterone Syst 2000 1: 268-272. [Abstract] [PDF] [References]  

Cornelius Müller, Anja Reddert, Sven Wassmann, Kerstin Strehlow, Michael Böhm, and Georg Nickenig

Insulin-like growth factor induces up-regulation of AT1-receptor gene expression in vascular smooth muscle cells
J Renin Angiotensin Aldosterone Syst 2000 1: 273-277. [Abstract] [PDF] [References]  

Jianhua Zhu and Danchen Gao

Losartan reduces collagen content and intimal thickening of iliac arteries after balloon injury in rabbits
J Renin Angiotensin Aldosterone Syst 2000 1: 278-282. [Abstract] [PDF] [References]  

Frederik LP Fierens, Patrick ML Vanderheyden, Zsuzsanna Gáborik, Tam Le Minh, Jean-Paul De Backer, László Hunyady, Adriaan Ijzerman, and Georges Vauquelin

Lys 199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists
J Renin Angiotensin Aldosterone Syst 2000 1: 283-288. [Abstract] [PDF] [References]  

Spyros Nikas, Evangellos Rizos, Haralampos Milionis, Eleni Bairaktari, Rigas Kalaitzidis, Kostas Siamopoulos, and Moses Elisaf

The effects of the addition of losartan on uric acid metabolism in patients receiving indapamide
J Renin Angiotensin Aldosterone Syst 2000 1: 289-291. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.